Cour Pharmaceuticals CEO John Puisis talks $105M funding round
Puisis spoke with MM+M about Cour Pharmaceuticals' funding, the autoimmune treatment space and the potential of Chicago’s biotech scene.
Source: mmm-online.com
John Puisis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from John Puisis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In John Puisis Today - Breaking & Trending Today
This Biotech Startup Just Raised $105M to Extinguish Inflammation at the Source
Cour Pharmaceuticals’ nanoparticles reprogram the immune system to stop inflammation behind autoimmune disease. Three big pharma companies joined the startup’s Series A financing, which will fund clinical trials in type 1 diabetes and myasthenia gravis.
Source: medcitynews.com
COUR PHARMACEUTICALS APPOINTS BRIAN C. BOCK AS CHIEF FINANCIAL OFFICER
/PRNewswire/ -- COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders, today announced...
Source: prnewswire.com
COUR Pharmaceuticals Receives FDA Fast Track Designation for CNP-104 for the Treatment of Primary Biliary Cholangitis
/PRNewswire/ -- COUR Pharmaceuticals, a biotechnology company developing novel immune-modifying nanoparticles (CNPs) to treat immune disorders, today announced...
Source: prnewswire.com